1-[2-[(5-Cyanopyridin-2-yl)amino]ethylamino]acetyl-2-(S)-pyrrolidinecarbonitrile: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties
Furthermore, studies have examined these effects in fibroblast and keratinocyte cultures, endothelial and neuronal systems, and preclinical animal models related to wound repair and tissue response
Some studies suggest that inflammatory molecules called cytokines may play a role in triggering headaches after IVIG
Without an insulin comparison, a selective inhibitor or a null background, an effect measured after adding this protein cannot be assigned cleanly to IGF-1R as opposed to the insulin receptor or to hybrid receptors
Clin Exp Allergy 28(4):510512 Hansbrough JR, Wedner HJ, Chaplin DD (1987) Anaphylaxis to intravenous furosemide